Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: A single-dose, randomized, open-label, crossover study
Boellner, Samuel W., MD, Stark, Jeffrey G., PhD, Krishnan, Suma, MS, Zhang, Yuxin, PhD
Published in Clinical therapeutics (01.02.2010)
Published in Clinical therapeutics (01.02.2010)
Get full text
Journal Article
Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: A multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials
Findling, Robert L., MD, Wigal, Sharon B., PhD, Bukstein, Oscar G., MD, MPH, Boellner, Samuel W., MD, Abikoff, Howard B., PhD, Turnbow, John M., MD, CPI, Civil, Rich, MD
Published in Clinical therapeutics (01.08.2009)
Published in Clinical therapeutics (01.08.2009)
Get full text
Journal Article